Skip to main content
Profound Medical Corp. logo

Profound Medical Corp. — Investor Relations & Filings

Ticker · PROF TSX Manufacturing
Open in API
Filings indexed 256 across all filing types
Latest filing 2026-04-22 Proxy Solicitation & In…
Country CA Canada
Listing TSX PROF

About Profound Medical Corp.

https://profoundmedical.com/

Profound Medical Corp. is a commercial-stage medical technology company specializing in incision-free ablative therapies. Its core product is TULSA-PRO®, a therapeutic platform designed for the treatment of localized prostate cancer, radiorecurrent prostate cancer, and benign prostatic hyperplasia (BPH). TULSA-PRO utilizes a robotically controlled, transurethral ultrasound ablation procedure guided by real-time Magnetic Resonance (MR) imaging. This system employs closed-loop temperature feedback to ensure precise and customizable tissue ablation, prioritizing patient safety and minimizing complications. The technology merges MR imaging, thermal ultrasound, and robotics to offer a durable and accurate treatment delivery method.

Recent filings

Filing Released Lang Actions
Certificate re dissemination to shareholders.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a letter from TSX Trust Company confirming the mailing of proxy-related materials (Proxy with Request for Financial Statements, Voting Instruction Form, Notice of Meeting Combined with Information Circular) to shareholders. This clearly pertains to proxy solicitation materials and information statements sent to shareholders ahead of a meeting, matching the definition of a Proxy Solicitation & Information Statement. Therefore, the appropriate classification is PSI.
2026-04-22 English
Certificate re dissemination to shareholders.pdf
Audit Report / Information Classification · 1% confidence The document is the Independent Auditor’s Report of dmcl LLP on Sitka Gold Corp’s consolidated financial statements, followed by the audited consolidated statements of financial position, comprehensive loss, changes in equity and cash flows. It lacks broader narrative sections typical of full Annual Reports (10-K) such as MD&A, but rather is the standalone audit opinion and financial statements. This fits the definition of a standalone Audit Report / Information.
2026-04-22 English
Certificate re dissemination to shareholders.pdf
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a transmittal letter from TSX Trust Company confirming the mailing of proxy-related materials (Proxy, Voting Instruction Form, Notice of Meeting combined with Information Circular, etc.) to securityholders. This clearly pertains to proxy solicitation and information statement materials. Therefore it is classified as Proxy Solicitation & Information Statement (PSI).
2026-04-22 English
Notice of meeting - English.pdf
Audit Report / Information Classification · 1% confidence The document is a standalone statutory CEO declaration under section 295A(2) of the Australian Corporations Act, confirming proper maintenance of records and fairness of the financial statements for the year ended 31 December 2025. It is not a full annual report, nor a mere announcement. This form of compliance statement is part of audit documentation rather than a management discussion, earnings release, or governance amendment. Therefore, it is best classified as an Audit Report / Information.
2026-04-21 English
Notice of meeting - English.pdf
Regulatory Filings Classification · 1% confidence The document is a standalone Chief Executive Officer’s statutory declaration under section 295A(2) of the Corporations Act relating to the financial year ended 31 December 2025. It is not a full annual report (10-K/Annual Report), nor an audit report by external auditors, nor one of the other specified transaction or governance notices. As a miscellaneous regulatory filing that does not fit the other more specific categories, it best fits “Regulatory Filings” (RNS).
2026-04-21 English
Management information circular - English.pdf
Regulatory Filings
2026-04-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.